Literature DB >> 1444292

Microbiological efficacy and pharmacokinetics of prophylactic antibiotics in liver transplant patients.

P M Arnow1, K Furmaga, J P Flaherty, D George.   

Abstract

The pharmacokinetics of perioperative systemic antibiotics and the microbiological effectiveness of oral nonabsorbable antibiotics started immediately prior to surgery were studied in 18 adult patients undergoing liver transplantation. All patients received cefotaxime, 2 g intravenously, at 6-h intervals during surgery and then at 8-h intervals thereafter for 48 h; eight patients also received ampicillin at the same dose and schedule. This regimen produced levels of antibiotics in blood that appeared appropriate for prophylaxis. The first dose peak (68 +/- 18 micrograms/ml) and trough (6.9 +/- 4.7 micrograms/ml) levels of cefotaxime in serum and the first dose peak (73 +/- 22 micrograms/ml) and trough (4.1 +/- 2.3 micrograms/ml) levels of ampicillin in serum, which were assayed by high-performance liquid chromatography, were similar to levels reported in normal volunteers, despite mean intraoperative blood loss of 3.3 liters and fluid replacement of 21 liters. On postoperative days 1 and 2, the levels of cefotaxime and ampicillin were maintained at or above 0.9 and 1.3 micrograms/ml, respectively, with little accumulation. By random assignment, 8 patients received systemic antibiotics alone and 10 patients received systemic antibiotics plus a 3-week regimen of oral nonabsorbable antibiotics (gentamicin, polymyxin E, and nystatin) beginning when a donor liver was procured. Pre- and postoperative cultures of rectum, throat, and gastric aspirate samples showed persistence of aerobic gram-negative bacilli for the first 2 postoperative weeks in about half of the patients in each group. Failure of the regimen of oral nonabsorbable antibiotics to supplement cefotaxime in eradicating aerobic gram-negative bacilli from stools probably results from impaired peristalsis during and after surgery and warrants earlier initiation of the regimen.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1444292      PMCID: PMC245466          DOI: 10.1128/AAC.36.10.2125

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  Selective bowel decontamination for infection prophylaxis in liver transplantation patients.

Authors:  R H Wiesner
Journal:  Transplant Proc       Date:  1991-06       Impact factor: 1.066

2.  The effect of oral non-absorbable antibiotics on the emergence of resistant bacteria in patients in an intensive care unit.

Authors:  C P Stoutenbeek; H K van Saene; D F Zandstra
Journal:  J Antimicrob Chemother       Date:  1987-04       Impact factor: 5.790

3.  Ampicillin and hetacillin pharmacokinetics in normal and anephric subjects.

Authors:  W J Jusko; G P Lewis; G W Schmitt
Journal:  Clin Pharmacol Ther       Date:  1973 Jan-Feb       Impact factor: 6.875

4.  Postoperative wound infection: a prospective study of determinant factors and prevention.

Authors:  H C Polk; J F Lopez-Mayor
Journal:  Surgery       Date:  1969-07       Impact factor: 3.982

Review 5.  Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care.

Authors:  I M Ledingham; S R Alcock; A T Eastaway; J C McDonald; I C McKay; G Ramsay
Journal:  Lancet       Date:  1988-04-09       Impact factor: 79.321

6.  Effect of surgical blood loss and volume replacement on antibiotic pharmacokinetics.

Authors:  D Sue; T A Salazar; K Turley; B J Guglielmo
Journal:  Ann Thorac Surg       Date:  1989-06       Impact factor: 4.330

7.  Fungal infections in liver transplant recipients.

Authors:  C P Wajszczuk; J S Dummer; M Ho; D H Van Thiel; T E Starzl; S Iwatsuki; B Shaw
Journal:  Transplantation       Date:  1985-10       Impact factor: 4.939

8.  Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind, placebo-controlled study.

Authors:  H F Guiot; P J van den Broek; J W van der Meer; R van Furth
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

9.  Infections after liver transplantation. An analysis of 101 consecutive cases.

Authors:  S Kusne; J S Dummer; N Singh; S Iwatsuki; L Makowka; C Esquivel; A G Tzakis; T E Starzl; M Ho
Journal:  Medicine (Baltimore)       Date:  1988-03       Impact factor: 1.889

10.  Pharmacology of cefotaxime and its desacetyl metabolite in renal and hepatic disease.

Authors:  R Wise; N Wright; P J Wills
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

View more
  2 in total

1.  Plasma levels of piperacillin and vancomycin used as prophylaxis in liver transplant patients.

Authors:  M Dupon; G Janvier; G Vinçon; S Winnock; F Demotes-Mainard; O Capeyron; J Saric
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 2.  Antibiotic prophylaxis for surgical site infection in people undergoing liver transplantation.

Authors:  Ricardo A M B Almeida; Claudia N Hasimoto; Anna Kim; Erica N Hasimoto; Regina El Dib
Journal:  Cochrane Database Syst Rev       Date:  2015-12-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.